Member Info for dactions

Unfortunately, for reasons that I think none of us can truly interpret, we must await the FDA decision. Yes, I think it is a no-brainer and will be OK but the Barder has made such a meal of the FDA requirements he has built into his message unwittingly the possibility of failure - and that's what the market is not liking.

There was a 5 million SELL yesterday afternoon at 3.5p - so you may be right about Pension Funds - barnetpeter
WBI is good still very in my opinion but it's difficult to know what the big boys are likely to do.

It's worth bearing in mind too that in Germany precautions against Covid have recently been toughened as the incidence of Covid infections rise: https://amp.dw.com/en/new-german-covid-19-rules-come-into-force-as-infections-rise-in-colder-months/a-63305695

"it's not for sale yet"
Burgerneck - welcome back - it must be a year or more since you last commented on FUM. For all that the BoD have us told shareholders in the meantime, not a lot has happened that we can actually see. So, you've not missed much. However, ever so slowly, like a turning tanker, initial sales progress is promised soon. Will it be outside of the US by the end of this year or do we await for the final approval by the US Food and Drug Administration which could be sometime in the 1st quarter 2003 ?

I'm looking at a Daily Mail article headed: "Viagra too slow for you ? Now for the gel that works in 5 Mins" which if I recall correctly, propelled the sp to above 90p. Trouble is that was published 9th September 2016 !

But as 81 Lucky posted recently:
"Eroxon will be a market disruptor, if not in US, then in rest of the world. It's a win/win"

I believe that to be true. GLA

Thanks for the link Jet7 - but their analysis is very lightweight & done to promote themselves. I do agree though the institutions - Lobard Odier in particular - will do really well if Eroxon is successful. By rights, FUM in a year's time should be a completely different company with royalties and/or license income from sales. Perhaps it's more likely they'll be bought out ?

I wonder though - are we risk-free now ? Why does it take so long to get FDA approval ? I guess this is the real hurdle we need to get over - all the others being just stepping-stones in comparison. Once over, the sp should really rocket. Is it conceivable the FDA could find a reason to decline permission for Over the Counter sales ? If the market weren't so weak, I would be tempted to sell up elsewhere and reinvest in FUM but . . . there's always a 'but' with AIM shares.

"The Covid cases are rising rapidly so our revenue will also."

I agree jamrock - had quite a few unrelated contacts going down with Covid (I'm in south-east) - and all had got through their free packs of LFTs and needing to frequently test to ensure they're not infecting others. So, now buying them in.

I wonder if on balance they are sellers - beechknot ? Yes the sp was weaker but not sufficient in my opinion if the large trades declared several hours late this afternoon were all sellers. Will there be a TR1 Monday/Tuesday from a large holder perhaps that might explain things better?

However, I'm hoping though, we'll see an RNS next week on 3rd quarter's trading. The earlier months have been excellent this year and as I haven't heard anything politically negative coming from Gabon, the results trend should continue to be good. GLA

I agree Doc - see Before & After images from CNN
https://edition.cnn.com/2022/09/30/us/hurricane-ian-sanibel-before-after/index.html

There's always someone worse off than oneself.

Thanks wpa5

Proactive has made the figures and position the company is in so much better. The headings are correct and if we were starting from here the picture would look immensely rosy. Of course I recognise we are now looking at it with the jaundiced view of hindsight.

The sp could turn substantially on commercial news and it's worth therefore continuing to hold in my opinion. GLA

Thanks for link Trojan.
RM looked perhaps a little less assured this morning than hitherto - but the message remains the same - which in my words is effectively - we keep going forward. At this sp level, with sufficient funds for the next 12 months, in my opinion they have time to find partners/trials.

As a LTH and having been here before many years ago (pre.AstraZeneca), the sp could rub along the bottom pence range quite easily. So, I really hope that RM makes an effort tomorrow with his presentation. For all our sakes - not just mine. GLA

But the spread has widened .
Can there be much of a free float anymore with so many holders hanging on to their shares ?

What a surprise to read the latest announcement as I was eating my porridge this morning. I agree Truro Trader it reads surprisingly well and they only want another £10m to be a part of the party.

I like that the lines can be setup close to the site - presumably it's a messy process which would find difficulty in getting planning permission over here ? If only the first location wasn't in Albania where the corruption is even worse that Kosovo. Will Chris Gilbert be taking an active part greasing the politicians ?

On paper, it sounds so promising - but probably not to all those Fox shareholders like me backing a miserable investment all these years. Perhaps, for once, it will all turn out right for us ?

Well, back to my porridge. Good luck all.

Given the sharpness of the fall specific to FUM, suggests to me there is a larger SELL not yet reported.

Scharnhorst - you sum it up nicely.

- We didn't get any wellness figures - lots of nice words though.
- Regarding the background problems with Nell Health - we learned nothing other than Penny took quite a deep breath when the question was raised (negative body language ?) but she skimmed past it.
- We learned they save £25,000 per month by closing the Manchester lab - but it seems MHC happy to outsource it all to Acculabs - is that a wise business move ?
- the team is only 12 persons which must limit potential and explains why the 'wellness' products were delayed in my opinion - but she said they intend to expand numbers.
- and Adam (Chairman) when asked about shareprice being exactly the same (1.75p) as when they started in their new guise 2020 and yet now having turned a very useful profit, was rather sanguine with his answer - fault of AIM generally.

I don't want to be accused of being negative because the mood-music from Penny was really great - a lot rides on that one person's shoulders. If you're happy with that, then the current sp could eventually come to be seen as an absolute bargain.

GLA

Rogetrades - thanks for your informative insights.

jamrock & cuvio - there has clearly been a significant problem getting these 'wellness' products out.

Other contributors to this BB regularly pointed out the delay in getting them out - last year, the inference was they'd be out in the New Year and I don't believe for one moment the delay was because Management had other things to do. I can't recall in recent years of shares I have followed, whether owned or thinking about investing, where such a critical performance target was missed so completely that the Nell Health investors will miss out on £1 million MHC shares. What lies behind this ? Some of the original Nell Health are still around but is this going to cause them and MHC management problems ?

In other things, if we can be told that July was record-breaking, what about August's trading - the figures will be known but we're not being told despite it covering the main holiday travel period and Covid sales. Personally, I don't want to read more about future 'new' products, as good as I recognise they have to urgently build sales strength away from Covid, when we haven't had information on their existing 'new' ones.

I've received marketing emails on all of the current products - they're informative but I wouldn't say they 'sell' the products to me - there's no marketing thrust. There was a 'dynamism' this time last year, I'm concerned that I'm seeing a more pedestrian performance. Anyway, as I've already said I'm staying as a shareholder, but I am frustrated - I shall try to formulate one or two pertinent questions including about Nell Health and I recommend other shareholders consider doing the same.

GLA

Sorry correction:
3. Now we learn that Nell Health will not be receiving £1 million in shares as they have failed to meet performance targets.

I'm disappointed by the results - they're simply not good enough and the sp reflects that I regret to say. No amount of gilding the lilly will change things.

1. We have all known on this BB that the delivery of the 'Wellness' products is way beyond what was projected.
2. We have worked out for ourselves that sales have not yet happened - by the simple fact there are no TrustPilot reviews.
3. Now we learn that Nell Health will not be receiving £1 in shares as they have failed to meet performance targets. Those targets were sales of between £800,000 and £1,600.000 in 2022. I believe that is 12 months from takeover which was end June 2021.

I am still a holder of MHC shares so not in any way deramping the shares, but I had hoped in July that by today we would have seen a decent uplift of the sp to around 3.5p. But based on today's announcements, I can't see that happening until we see some meaningful sales figures from the 'Wellness' products. GLA

Yes - 250,000 free shares - very nice too - I've often thought this Company is one man's fiefdom. That said, I'm a long term holder and will remain so.